207670-43-7

Basic information

• Product Name: N-[[5-[3-trichloromethylcarbonyl]-[5H-pyrrolo-[2,1-c][1,4]-benzodiazepin-10(11H)-yl]carbonyl]-2-methoxyphenyl]-2-phenylbenzamide
• Synonyms: N-[[5-[3-trichloromethylcarbonyl]-[5H-pyrrolo-[2,1-c][1,4]-benzodiazepin-10(11H)-yl]carbonyl]-2-methoxyphenyl]-2-phenylbenzamide
• CAS NO: 207670-43-7
• Molecular Weight: 658.968
• Mol File: 207670-43-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-[[5-[3-trichloromethylcarbonyl]-[5H-pyrrolo-[2,1-c][1,4]-benzodiazepin-10(11H)-yl]carbonyl]-2-methoxyphenyl]-2-phenylbenzamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-[[5-[3-trichloromethylcarbonyl]-[5H-pyrrolo-[2,1-c][1,4]-benzodiazepin-10(11H)-yl]carbonyl]-2-methoxyphenyl]-2-phenylbenzamide(207670-43-7)
• EPA Substance Registry System: N-[[5-[3-trichloromethylcarbonyl]-[5H-pyrrolo-[2,1-c][1,4]-benzodiazepin-10(11H)-yl]carbonyl]-2-methoxyphenyl]-2-phenylbenzamide(207670-43-7)

Safety Data

• Hazardous Substances Data: 207670-43-7(Hazardous Substances Data)

Upstream product

• 76-02-8 trifluoroacetyl chloride 
• 200879-07-8 [3-Methoxy-4-(5H,11H-pyrrolo[2,1-c][1,4]-benzodiazepine-10-carbonyl)-phenyl]-biphenyl-2-carboxylic acid-amide 
• 207670-32-4 10-(4-[(biphenyl-2-carbonyl)amino]-2-methoxy-benzoyl)-10,11-dihydro-5H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-3-carboxylic acid-piperazine-N-methyl amide 
• 39106-79-1 methyl 2-methoxy-4-nitrobenzoate 
• 2597-56-0 4-nitro-o-anisic acid 
• 14002-52-9 o-phenylbenzoyl chloride 
• 27492-84-8 Methyl 4-amino-2-methoxybenzoate 
• 207670-44-8 10-(4-[(biphenyl-2-carbonyl)-amino]-2-methoxybenzoyl)-10,11-dihydro-5H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-3-carboxylic acid 
• 200879-10-3 4-[(biphenyl-2-carbonyl)-amino]-2-methoxy-benzoic acid 
• 200879-09-0 4-[(biphenyl-2-carbonyl)-amino]-2-methoxy-benzoic acid methyl ester 

Downstream Products

• 207670-44-8 10-(4-[(biphenyl-2-carbonyl)-amino]-2-methoxybenzoyl)-10,11-dihydro-5H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-3-carboxylic acid 

Relevant articles and documents

3-CARBOXAMIDE DERIVATIVES OF 5H-PYRROLO[2,1-c][1,4]-BENZODIAZEPINES

This invention relates to tricyclic non-peptide vasopressin antagonists which are useful in treating conditions where decreased vasopressin levels are desired, such as in congestive heart failure, in disease conditions with excess renal water reabsorption and in conditions with increased vascular resistance and coronary vasoconstriction, the compounds having general structure (I).